Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Herpes Labialis (Oral Herpes) Drugs Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Herpes Labialis (Oral Herpes) Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Valacyclovir
      • 1.3.3 Aciclovir
      • 1.3.4 Famciclovir
      • 1.3.5 Other
    • 1.4 Market Segment by Application
      • 1.4.1 Global Herpes Labialis (Oral Herpes) Drugs Market Share by Application (2019-2025)
      • 1.4.2 External use
      • 1.4.3 Oral
      • 1.4.4 Injection
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Herpes Labialis (Oral Herpes) Drugs Market Size
      • 2.1.1 Global Herpes Labialis (Oral Herpes) Drugs Revenue 2014-2025
      • 2.1.2 Global Herpes Labialis (Oral Herpes) Drugs Sales 2014-2025
    • 2.2 Herpes Labialis (Oral Herpes) Drugs Growth Rate by Regions
      • 2.2.1 Global Herpes Labialis (Oral Herpes) Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Herpes Labialis (Oral Herpes) Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Herpes Labialis (Oral Herpes) Drugs Sales by Manufacturers
      • 3.1.1 Herpes Labialis (Oral Herpes) Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Herpes Labialis (Oral Herpes) Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Herpes Labialis (Oral Herpes) Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Herpes Labialis (Oral Herpes) Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Herpes Labialis (Oral Herpes) Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Herpes Labialis (Oral Herpes) Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Herpes Labialis (Oral Herpes) Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Herpes Labialis (Oral Herpes) Drugs Market
    • 3.6 Key Manufacturers Herpes Labialis (Oral Herpes) Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Valacyclovir Sales and Revenue (2014-2019)
      • 4.1.2 Aciclovir Sales and Revenue (2014-2019)
      • 4.1.3 Famciclovir Sales and Revenue (2014-2019)
      • 4.1.4 Other Sales and Revenue (2014-2019)
    • 4.2 Global Herpes Labialis (Oral Herpes) Drugs Sales Market Share by Type
    • 4.3 Global Herpes Labialis (Oral Herpes) Drugs Revenue Market Share by Type
    • 4.4 Herpes Labialis (Oral Herpes) Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Herpes Labialis (Oral Herpes) Drugs Sales by Application

    6 United States

    • 6.1 United States Herpes Labialis (Oral Herpes) Drugs Breakdown Data by Company
    • 6.2 United States Herpes Labialis (Oral Herpes) Drugs Breakdown Data by Type
    • 6.3 United States Herpes Labialis (Oral Herpes) Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Herpes Labialis (Oral Herpes) Drugs Breakdown Data by Company
    • 7.2 European Union Herpes Labialis (Oral Herpes) Drugs Breakdown Data by Type
    • 7.3 European Union Herpes Labialis (Oral Herpes) Drugs Breakdown Data by Application

    8 China

    • 8.1 China Herpes Labialis (Oral Herpes) Drugs Breakdown Data by Company
    • 8.2 China Herpes Labialis (Oral Herpes) Drugs Breakdown Data by Type
    • 8.3 China Herpes Labialis (Oral Herpes) Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Herpes Labialis (Oral Herpes) Drugs Breakdown Data by Company
    • 9.2 Rest of World Herpes Labialis (Oral Herpes) Drugs Breakdown Data by Type
    • 9.3 Rest of World Herpes Labialis (Oral Herpes) Drugs Breakdown Data by Application
    • 9.4 Rest of World Herpes Labialis (Oral Herpes) Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Herpes Labialis (Oral Herpes) Drugs Sales by Countries
      • 9.4.2 Rest of World Herpes Labialis (Oral Herpes) Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 GSK
      • 10.1.1 GSK Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Herpes Labialis (Oral Herpes) Drugs
      • 10.1.4 Herpes Labialis (Oral Herpes) Drugs Product Introduction
      • 10.1.5 GSK Recent Development
    • 10.2 Novartis
      • 10.2.1 Novartis Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Herpes Labialis (Oral Herpes) Drugs
      • 10.2.4 Herpes Labialis (Oral Herpes) Drugs Product Introduction
      • 10.2.5 Novartis Recent Development
    • 10.3 Teva
      • 10.3.1 Teva Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Herpes Labialis (Oral Herpes) Drugs
      • 10.3.4 Herpes Labialis (Oral Herpes) Drugs Product Introduction
      • 10.3.5 Teva Recent Development
    • 10.4 Apotex
      • 10.4.1 Apotex Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Herpes Labialis (Oral Herpes) Drugs
      • 10.4.4 Herpes Labialis (Oral Herpes) Drugs Product Introduction
      • 10.4.5 Apotex Recent Development
    • 10.5 Cadila
      • 10.5.1 Cadila Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Herpes Labialis (Oral Herpes) Drugs
      • 10.5.4 Herpes Labialis (Oral Herpes) Drugs Product Introduction
      • 10.5.5 Cadila Recent Development
    • 10.6 Mylan
      • 10.6.1 Mylan Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Herpes Labialis (Oral Herpes) Drugs
      • 10.6.4 Herpes Labialis (Oral Herpes) Drugs Product Introduction
      • 10.6.5 Mylan Recent Development
    • 10.7 HETERO
      • 10.7.1 HETERO Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Herpes Labialis (Oral Herpes) Drugs
      • 10.7.4 Herpes Labialis (Oral Herpes) Drugs Product Introduction
      • 10.7.5 HETERO Recent Development
    • 10.8 Beech Tree
      • 10.8.1 Beech Tree Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Herpes Labialis (Oral Herpes) Drugs
      • 10.8.4 Herpes Labialis (Oral Herpes) Drugs Product Introduction
      • 10.8.5 Beech Tree Recent Development
    • 10.9 Onxeo
      • 10.9.1 Onxeo Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Herpes Labialis (Oral Herpes) Drugs
      • 10.9.4 Herpes Labialis (Oral Herpes) Drugs Product Introduction
      • 10.9.5 Onxeo Recent Development
    • 10.10 Foamix
      • 10.10.1 Foamix Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Herpes Labialis (Oral Herpes) Drugs
      • 10.10.4 Herpes Labialis (Oral Herpes) Drugs Product Introduction
      • 10.10.5 Foamix Recent Development
    • 10.11 Roxane
    • 10.12 Livzon
    • 10.13 Luoxin
    • 10.14 Med shine
    • 10.15 Haiwang
    • 10.16 Kelun Group

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Herpes Labialis (Oral Herpes) Drugs Sales Channels
      • 11.2.2 Herpes Labialis (Oral Herpes) Drugs Distributors
    • 11.3 Herpes Labialis (Oral Herpes) Drugs Customers

    12 Market Forecast

    • 12.1 Global Herpes Labialis (Oral Herpes) Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Herpes Labialis (Oral Herpes) Drugs Sales Forecast by Type
    • 12.3 Global Herpes Labialis (Oral Herpes) Drugs Sales Forecast by Application
    • 12.4 Herpes Labialis (Oral Herpes) Drugs Forecast by Regions
      • 12.4.1 Global Herpes Labialis (Oral Herpes) Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Herpes Labialis (Oral Herpes) Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Herpes Labialis (Oral Herpes) Drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Herpes Labialis (Oral Herpes) Drugs.

      This report studies the global market size of Herpes Labialis (Oral Herpes) Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Herpes Labialis (Oral Herpes) Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      GSK
      Novartis
      Teva
      Apotex
      Cadila
      Mylan
      HETERO
      Beech Tree
      Onxeo
      Foamix
      Roxane
      Livzon
      Luoxin
      Med shine
      Haiwang
      Kelun Group

      Market Segment by Product Type
      Valacyclovir
      Aciclovir
      Famciclovir
      Other

      Market Segment by Application
      External use
      Oral
      Injection

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Herpes Labialis (Oral Herpes) Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Herpes Labialis (Oral Herpes) Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Herpes Labialis (Oral Herpes) Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now